Shares of Fortis Healthcare Ltd gained more than 2% in the morning trade on February 16, a day after the mass media described that its secondary SRL Diagnostics was scheduling to increase funds through an initial public offering (IPO).

At 10.41 am, Fortis Healthcare Limited was swapping at Rs 275 on BSE, up 2.1% from its preceding day’s close.

According to the media, SRL Diagnostics has introduced preliminary discussions with investment bankers to rope in advisers as the firm is appraising an IPO to raise around Rs 2,000 crore.

SRL Diagnostics is India’s principal chain of diagnostic laboratories by geographic attendance and the only laboratory with a pan-India occurrence. It is the second-largest diagnostics restraint in the country about income after Dr Lal Pathlabs.

The promoter group of SRL Diagnostics holds a 57.68% stake, while the bloc of private equity depositors, which comprises the likes of NY Jacob Ballas and the World Bank’s expansion finance arm IFC, holds 31.52%.